title: RETRACTED: Probucol via inhibition of NHE1 attenuates LPS-accelerated atherosclerosis and promotes plaque stability in vivo.
abstract: This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
  
  This article has been retracted at the request of the authors.
  
  Concern had previously been raised about the veracity of some of the data in Figure 6 which appears to contain similar experimental data to many other publications, described here: https://pubpeer.com/publications/72ACDBE9751C8FD443A223FEB806E8#. The corresponding author contacted the journal and acknowledged that some of the experiments were not conducted by the authors themselves and they no longer have confidence in the reliability of the results. The authors would like to apologize for any inconvenience caused. The Editor-in-Chief agreed to retract the article.
authors.affiliation: Department of Cardiology, The 4th Hospital of Harbin Medical University, Harbin 150001, China.
authors.forename: Jian-Fei
authors.initials: JF
authors.lastname: Li
authors.affiliation: Department of Cardiology, The 4th Hospital of Harbin Medical University, Harbin 150001, China.
authors.forename: Song
authors.initials: S
authors.lastname: Chen
authors.affiliation: Health examination center, Hospital of Heilongjiang Armed Police Corps, 558 Xinyanglu Road, Harbin 150076, China.
authors.forename: Jun-Duo
authors.initials: JD
authors.lastname: Feng
authors.affiliation: Department of Cardiology, The 4th Hospital of Harbin Medical University, Harbin 150001, China.
authors.forename: Ming-Yu
authors.initials: MY
authors.lastname: Zhang
authors.affiliation: Department of Cardiology, The 4th Hospital of Harbin Medical University, Harbin 150001, China.
authors.forename: Xiao-Xia
authors.initials: XX
authors.lastname: Liu
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002154:Calpain / Q000008:administration & dosage; D027682:Cation Transport Proteins / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D008070:Lipopolysaccharides / Q000633:toxicity; D051379:Mice; D058226:Plaque, Atherosclerotic / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D011341:Probucol / Q000008:administration & dosage; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis*; D000074082:Sodium-Hydrogen Exchanger 1; D017923:Sodium-Hydrogen Exchangers / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D027682:Cation Transport Proteins; D008070:Lipopolysaccharides; D019253:Proto-Oncogene Proteins c-bcl-2; C490998:SLC9A1 protein, human; D000074082:Sodium-Hydrogen Exchanger 1; D017923:Sodium-Hydrogen Exchangers; D002154:Calpain; D011341:Probucol; D002118:Calcium
keywords: Atherosclerosis; Lipopolysaccharide; Na(+)/H(+) exchanger 1; Plaque stability; Probucol